01 1DIJIA PHARMACEUTICAL GROUP CO., LTD. Weihai CN
02 1Orion Corporation Fermion Espoo FI
03 1SRI KRISHNA PHARMACEUTICALS LIMITED Hyderabad IN
04 1TAIZHOU HIGHSUN PHARMACEUTICAL CO., LTD. Duqiao CN
05 1Unichem Laboratories Limited Mumbai IN
06 1Urquima S.A. Sant Fost De Campsentelles ES
01 5Glipizide
02 1Glipizide, Regular - Micronised
01 2China
02 1Finland
03 2India
04 1Spain
01 1Expired
02 3Valid
03 1Withdrawn by EDQM Failure to CEP procedure
04 1Withdrawn by Holder
Certificate Number : CEP 2014-070 - Rev 01
Status : Valid
Issue Date : 2025-01-23
Type : Chemical
Substance Number : 906
Certificate Number : R1-CEP 2008-210 - Rev 00
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2015-02-17
Type : Chemical
Substance Number : 906
Certificate Number : R0-CEP 2015-107 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2019-04-12
Type : Chemical
Substance Number : 906
Glipizide, Regular - Micronised
Certificate Number : R1-CEP 1997-114 - Rev 04
Status : Valid
Issue Date : 2011-07-08
Type : Chemical
Substance Number : 906
Certificate Number : R1-CEP 2012-117 - Rev 02
Status : Valid
Issue Date : 2020-04-23
Type : Chemical
Substance Number : 906
Certificate Number : R0-CEP 2001-067 - Rev 01
Status : Expired
Issue Date : 2004-11-26
Type : Chemical
Substance Number : 906
33
PharmaCompass offers a list of Glipizide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Glipizide manufacturer or Glipizide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Glipizide manufacturer or Glipizide supplier.
PharmaCompass also assists you with knowing the Glipizide API Price utilized in the formulation of products. Glipizide API Price is not always fixed or binding as the Glipizide Price is obtained through a variety of data sources. The Glipizide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Glipizide Extended-Release Tablets manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glipizide Extended-Release Tablets, including repackagers and relabelers. The FDA regulates Glipizide Extended-Release Tablets manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glipizide Extended-Release Tablets API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Glipizide Extended-Release Tablets manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Glipizide Extended-Release Tablets supplier is an individual or a company that provides Glipizide Extended-Release Tablets active pharmaceutical ingredient (API) or Glipizide Extended-Release Tablets finished formulations upon request. The Glipizide Extended-Release Tablets suppliers may include Glipizide Extended-Release Tablets API manufacturers, exporters, distributors and traders.
click here to find a list of Glipizide Extended-Release Tablets suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Glipizide Extended-Release Tablets CEP of the European Pharmacopoeia monograph is often referred to as a Glipizide Extended-Release Tablets Certificate of Suitability (COS). The purpose of a Glipizide Extended-Release Tablets CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Glipizide Extended-Release Tablets EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Glipizide Extended-Release Tablets to their clients by showing that a Glipizide Extended-Release Tablets CEP has been issued for it. The manufacturer submits a Glipizide Extended-Release Tablets CEP (COS) as part of the market authorization procedure, and it takes on the role of a Glipizide Extended-Release Tablets CEP holder for the record. Additionally, the data presented in the Glipizide Extended-Release Tablets CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Glipizide Extended-Release Tablets DMF.
A Glipizide Extended-Release Tablets CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Glipizide Extended-Release Tablets CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Glipizide Extended-Release Tablets suppliers with CEP (COS) on PharmaCompass.
We have 5 companies offering Glipizide Extended-Release Tablets
Get in contact with the supplier of your choice:
